FluoroPharma Medical Secures $2,355,621 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=724d02c2-d2ff-491b-99f2-8a110149b4ba&Preview=1 - Date
7/11/2011 - Company Name
FluoroPharma Medical - Mailing Address
500 Boylston Street Boston, MA 02116 - Company Description
FluoroPharma, Inc., a privately-held molecular imaging company headquartered in Boston MA, engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD). - Website
http://www.fluoropharma.com - Transaction Type
Venture Equity - Transaction Amount
$2,355,621 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
